"Real world" eligibility for aducanumab

J Am Geriatr Soc. 2021 Oct;69(10):2995-2998. doi: 10.1111/jgs.17390. Epub 2021 Jul 31.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / drug therapy*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Eligibility Determination*
  • Female
  • Humans
  • Male

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab